These data, establishing STAT1 as a tumor suppressor, are substantiated by those of Widschwendter et al. [116] who correlated STAT1 expression and activity with a more favorable prognosis, notably in TNBC and HER2+ subtypes. Here, STAT1 is linked to neoplasm.